The ubiquitin-proteasome pathway is a new partner for the control of insulin signaling.

Abstract

International audienceInsulin signaling is a transitory effect that has to be tightly controlled in magnitude and duration in order to maintain cell homeostasis. Recent reports have demonstrated that members of the ubiquitin-proteasome pathway represent new partners that have to be taken into account for the regulation of insulin action